Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study) – NEURO-ONCOLOGY

Márquez-Rodas, I; Alvarez, A; Arance, A; Valduvieco, I; Berciano-Guerrero, MA; Delgado, R; Soria, A; Campos, FL; Sánchez, P; Romero, JL; Martin-Liberal, J; Lucas, A; Díaz-Beveridge, R; Conde-Moreno, AJ; de la Gala, MDA; García-Castaño, A; Prada, PJ; Cao, MG; Puertas, E; Vidal, J; Foro, P; de la Rosa, CA; Corona, JA; Cerezuela-Fuentes, P; López, P; Luna, P; Aymar, N; Puértolas, T; Sanagustín, P; Berrocal, A – 2024 – 10.1093/neuonc/noae116